ID   CHLA-140
AC   CVCL_6592
DR   Cosmic; 930055
DR   Wikidata; Q54812162
RX   PubMed=11212268;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-140_Cell_Line_Data_Sheet_COGcell_org.pdf
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13.2,15
ST   D21S11: 30,32
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 25,26
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
RX   PubMed=11212268;
RA   Thompson, Patricia M.
RA   Maris, John Matthew
RA   Hogarty, Michael D.
RA   Seeger, Robert C.
RA   Reynolds, Charles Patrick
RA   Brodeur, Garrett M.
RA   White, Peter S.
RT   "Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36
RT   or at other tumor suppressor loci in neuroblastoma.";
RL   Cancer Res. 61:679-686(2001).
//